Paris, France

Laurent Ferradini



Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 1997-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Laurent Ferradini

Introduction

Laurent Ferradini is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the area of human T lymphocyte receptors. With a total of 8 patents to his name, Ferradini's work has had a substantial impact on diagnostic and therapeutic applications.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses." This invention relates to new nucleotide sequences that code for variable regions of β chains of human T lymphocyte receptors, along with their corresponding peptide segments and their potential diagnostic and therapeutic uses. This innovative work showcases Ferradini's commitment to advancing medical science.

Career Highlights

Throughout his career, Ferradini has worked with notable companies such as Roussel Uclaf and Aventis Pharma. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.

Collaborations

Ferradini has had the opportunity to work alongside esteemed colleagues, including Thierry Hercend and Frederic Triebel. These collaborations have further enriched his research and innovation efforts.

Conclusion

Laurent Ferradini's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of diagnostic and therapeutic solutions, making a lasting impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…